
Doctor David Corcoran
Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD).
Presentation



